OTCMKTS:GTBIF - Green Thumb Industries Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $49.88
  • Forecasted Upside: 67.99 %
  • Number of Analysts: 11
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 11 Buy Ratings
  • 0 Strong Buy Ratings
$29.69
▼ -0.76 (-2.50%)
1 month | 3 months | 12 months
Get New Green Thumb Industries Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for GTBIF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for GTBIF

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$49.88
▲ +67.99% Upside Potential
This price target is based on 11 analysts offering 12 month price targets for Green Thumb Industries in the last 3 months. The average price target is $49.88, with a high forecast of $71.50 and a low forecast of $38.00. The average price target represents a 67.99% upside from the last price of $29.69.

Buy

The current consensus among 11 contributing investment analysts is to buy stock in Green Thumb Industries. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 6 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/23/2019
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/22/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/20/2020
  • 0 strong buy ratings
  • 9 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/18/2020
  • 0 strong buy ratings
  • 9 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/17/2020
  • 0 strong buy ratings
  • 10 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/17/2021
  • 0 strong buy ratings
  • 11 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/16/2021
  • 0 strong buy ratings
  • 11 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/15/2021

Latest Recommendations

  • 0 strong buy ratings
  • 11 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
5/13/2021Canaccord GenuityBoost Price TargetBuy$52.00 ➝ $54.00
i
5/13/2021Cantor FitzgeraldReiterated RatingBuy$43.00
i
Rating by Pablo Zuanic at Cantor Fitzgerald
3/31/2021Needham & Company LLCReiterated RatingBuy$47.25
i
3/18/2021Craig HallumBoost Price Target$55.00 ➝ $60.00
i
3/18/2021Alliance Global PartnersBoost Price TargetBuy$50.00 ➝ $55.00
i
3/18/2021Piper SandlerBoost Price TargetOverweight$35.00 ➝ $40.00
i
3/18/2021Roth CapitalBoost Price TargetBuy$40.00 ➝ $45.00
i
3/18/2021Needham & Company LLCBoost Price TargetBuy$46.75 ➝ $47.25
i
3/18/2021CowenBoost Price TargetTop Pick ➝ Outperform$30.00 ➝ $45.00
i
3/18/2021Cantor FitzgeraldLower Price TargetOverweight$62.00 ➝ $50.00
i
3/11/2021Needham & Company LLCReiterated RatingBuy$46.75
i
3/8/2021BTIG ResearchInitiated CoverageBuy
i
2/25/2021Stifel NicolausBoost Price TargetBuy$46.00 ➝ $71.50
i
2/11/2021Cantor FitzgeraldBoost Price TargetOverweight$35.00 ➝ $62.00
i
1/20/2021Roth CapitalBoost Price TargetBuy$29.00 ➝ $40.00
i
1/19/2021Needham & Company LLCBoost Price TargetBuy$39.00 ➝ $46.75
i
1/13/2021Echelon Wealth PartnersReiterated RatingBuy$38.00
i
1/6/2021Needham & Company LLCReiterated RatingBuy$39.00
i
11/12/2020Stifel NicolausBoost Price TargetBuy$44.00 ➝ $46.00
i
11/12/2020Canaccord GenuityBoost Price TargetBuy$27.00 ➝ $34.00
i
11/12/2020Craig HallumBoost Price TargetTop Pick ➝ Buy$25.00 ➝ $35.00
i
11/12/2020Alliance Global PartnersBoost Price TargetBuy$28.00 ➝ $40.00
i
11/12/2020Needham & Company LLCBoost Price TargetBuy$23.00 ➝ $39.00
i
11/12/2020Cantor FitzgeraldBoost Price TargetOverweight$29.00 ➝ $35.00
i
Rating by Pablo Zuanic at Cantor Fitzgerald
11/3/2020Needham & Company LLCBoost Price TargetBuy$21.50 ➝ $23.00
i
10/5/2020Echelon Wealth PartnersReiterated RatingBuy
i
9/2/2020Cantor FitzgeraldBoost Price TargetOverweight$27.00 ➝ $29.00
i
Rating by Pablo Zuanic at Cantor Fitzgerald
8/13/2020Stifel NicolausBoost Price TargetBuy$34.00 ➝ $42.50
i
8/13/2020Canaccord GenuityBoost Price TargetBuy$22.00 ➝ $27.00
i
8/13/2020Piper SandlerBoost Price TargetOverweight$12.00 ➝ $20.00
i
8/13/2020Craig HallumBoost Price TargetBuy$18.00 ➝ $25.00
i
8/13/2020Needham & Company LLCBoost Price TargetBuy$20.50 ➝ $21.50
i
8/13/2020Cantor FitzgeraldBoost Price TargetOverweight$21.00 ➝ $27.00
i
Rating by Pablo Zuanic at Cantor Fitzgerald
8/5/2020Needham & Company LLCBoost Price TargetBuy$13.00 ➝ $20.50
i
7/22/2020Stifel NicolausInitiated CoverageBuy
i
5/18/2020Cantor FitzgeraldUpgradeNeutral ➝ Overweight$9.60 ➝ $15.00
i
Rating by Pablo Zuanic at Cantor Fitzgerald
5/15/2020Needham & Company LLCBoost Price TargetBuy$11.00 ➝ $12.25
i
4/28/2020Needham & Company LLCInitiated CoverageBuy$11.00
i
3/27/2020Piper SandlerLower Price TargetOverweight$16.00 ➝ $12.00
i
2/21/2020LADENBURG THALM/SH SHInitiated CoverageBuy
i
2/13/2020Cantor FitzgeraldInitiated CoverageNeutral$13.00
i
1/8/2020Echelon Wealth PartnersReiterated RatingBuy$24.00
i
11/21/2019Alliance Global PartnersReiterated RatingBuy
i
Rating by Aaron Grey at Alliance Global Partners
9/19/2019Alliance Global PartnersInitiated CoverageBuy
i
9/13/2019CowenInitiated CoverageOutperform$18.50
i
8/12/2019Piper Jaffray CompaniesInitiated CoverageOverweight ➝ Overweight$13.00
i
6/10/2019Compass PointInitiated CoverageBuy
i
2/21/2019Seaport Global SecuritiesInitiated CoverageBuy ➝ Buy$16.00
i
1/31/2019BenchmarkInitiated CoverageBuy$16.00
i
(Data available from 6/16/2016 forward)
Green Thumb Industries logo
Green Thumb Industries Inc. manufactures, distributes, and sells various cannabis products for medical and adult-use in the United States. It offers cannabis flower; and processed and packaged products, including concentrates, edibles, and topical and other cannabis products under the Rythm, Dogwalkers, The Feel Collection, incredibles, Dr. Solomon's, Beboe, and other brands. The company distributes its products primarily to third-party retail stores, as well as sells finished products directly to consumers in its own retail stores. As of March 25, 2021, it owned and operated 55 retail stores in the United States. The company was founded in 2014 and is headquartered in Chicago, Illinois.
Read More

Today's Range

Now: $29.69
$29.41
$30.68

50 Day Range

MA: $29.38
$26.82
$32.00

52 Week Range

Now: $29.69
$9.35
$39.11

Volume

185,534 shs

Average Volume

646,945 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Green Thumb Industries?

The following equities research analysts have issued research reports on Green Thumb Industries in the last year: Alliance Global Partners, BTIG Research, Canaccord Genuity, Cantor Fitzgerald, Cowen Inc, Craig Hallum, Echelon Wealth Partners, Needham & Company LLC, Piper Sandler, Roth Capital, and Stifel Nicolaus.
View the latest analyst ratings for GTBIF.

What is the current price target for Green Thumb Industries?

10 Wall Street analysts have set twelve-month price targets for Green Thumb Industries in the last year. Their average twelve-month price target is $49.88, suggesting a possible upside of 63.8%. Stifel Nicolaus has the highest price target set, predicting GTBIF will reach $71.50 in the next twelve months. Echelon Wealth Partners has the lowest price target set, forecasting a price of $38.00 for Green Thumb Industries in the next year.
View the latest price targets for GTBIF.

What is the current consensus analyst rating for Green Thumb Industries?

Green Thumb Industries currently has 11 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe GTBIF will outperform the market and that investors should add to their positions of Green Thumb Industries.
View the latest ratings for GTBIF.

What other companies compete with Green Thumb Industries?

How do I contact Green Thumb Industries' investor relations team?

The company's listed phone number is 312-471-6720. The official website for Green Thumb Industries is www.gtigrows.com.